Andere talen Johnson & Johnson Swiss Exchange

Aandelen

JNJ

US4781601046

Beurs gesloten - Swiss Exchange Andere beurzen 17:36:39 01-03-2023			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
500 ^CHF	+194,12%		-.--%	-.--%

31/05	Sectorupdate: Gezondheidszorgaandelen hoger aan het eind van de middag	MT
31/05	Amerikaanse wetgevers vragen FBI om briefing over banden GenScript Biotech met China	RE

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Sector Update: Health Care Stocks Higher Late Afternoon	31/05
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	31/05
Sector Update: Health Care Stocks Advance Friday Afternoon	31/05
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	31/05
Johnson & Johnson Closes Acquisition of Shockwave Medical	31/05
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	31/05
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30/05
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM	29/05
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	29/05
J&J's treatment for depression succeeds in late stage study	29/05
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	29/05
Sector Update: Health Care Stocks Fall Late Afternoon	28/05
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28/05
Sector Update: Health Care	28/05
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	28/05
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	28/05
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	28/05
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28/05
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28/05
J&J acquires rights to skin disorder drug for $1.25 bln	28/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

De geneesmiddelenpijplijn is goed gepositioneerd voor 2024, zegt J&J CFO

23 januari 2024 om 18:30 uur